Skip to main content

Multimedia

May 23, 2020
In this video, Ann Childress, MD, shares strategies and tips for treating children and adolescents with attention-deficit/hyperactivity disorder (ADHD) during the COVID-19 pandemic.
May 22, 2020
Join Psych Congress Steering Committee member Saundra Jain, MA, PsyD, LPC, a body scan meditation, a type of meditation which promotes greater awareness of the physical body.
May 21, 2020
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, shares 5 suggestions for optimizing care for patients with attention-deficit/hyperactivity disorder (ADHD) during the pandemic.
May 13, 2020
Psych Congress cochair Charles Raison, MD, discusses the role of inflammation in mental health and lessons he has learned during the pandemic.
May 13, 2020
Psych Congress cochair Charles Raison, MD, speaks about how the COVID-19 pandemic has affected him personally and professionally and its impacts on clinical research studies and funding sources.
May 11, 2020
Psych Congress Steering Committee member Edward Kaftarian, MD, talks about the ramifications of the COVID-19 pandemic and his learnings from the crisis.
May 05, 2020
In this video, Robert Rymowicz, DO, of the Rutgers New Jersey Medical School, discusses food addiction, how highly processed foods affect the brain, and treatment strategies.
April 30, 2020
Kevin Taggart, CM&AP, managing partner of the healthcare M&A firm Mertz Taggart, joined the BHE Podcast to discuss a busy first quarter for merger and acquisition activity for the behavioral healthcare space. Plus, Taggart dives into trends to keep an eye on—banks tightening lending standards, challenges for center-based programs, and the emergence of telehealth—and the factors that could…
April 30, 2020
Jair Soares, MD, PhD, of the University of Texas, discusses why bipolar disorder is difficult to diagnose, diagnostic strategies, and common errors made in evaluating patients for the disorder.
April 27, 2020
In this podcast, Crystal T. Clark, MD, MSc, discusses the treatment of perinatal patients with mood disorders, including challenges clinicians face, pharmacological strategies, and nonpharmacological approaches.
Back to Top